Rapid brain tumor detection device tested in operating room

NCT ID NCT06098248

Terminated Diagnosis Sponsor: VPIX Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new imaging device called cCeLL-Ex vivo that uses laser microscopy to quickly detect brain tumors during surgery. The goal was to see if it could diagnose tumors faster than the standard frozen section method, which takes 20-30 minutes. The study enrolled 285 patients but was terminated early, so the full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cCeLL-Ex vivo device (confocal laser fluorescence microscopy)
What this could lead to: If successful, this device could help surgeons diagnose brain tumors faster during surgery, potentially reducing operating time.
What could go wrong: The study was terminated early, so results are limited. The device is still experimental and not yet proven to replace standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign neoplasm of brain brain cancer brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN BRAIN TUMOR MALIGNANT BRAIN TUMOR

Contacts and locations

Locations

Korea University Anam Hospital

Seoul, South Korea
Samsung Medical Center

Seoul, South Korea
Seoul National University Hospital

Seoul, South Korea
St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.